UK markets open in 2 hours 41 minutes

Provectus Biopharmaceuticals, Inc. (PVCT)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1860-0.0040 (-2.10%)
At close: 03:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
1,756
1,749
2,389
2,608
2,813
-
Selling general and administrative
1,423
1,732
2,025
2,055
2,145
-
Total operating expenses
2,575
2,910
3,391
4,636
4,932
-
Operating income or loss
-2,575
-2,910
-3,391
-4,636
-4,932
-
Interest expense
227.75
216.214
163.691
961.698
1,748
-
Total other income/expenses net
-
24.227
0.433
58.174
-1.273
-
Income before tax
-2,778
-3,102
-3,555
-5,540
-6,678
-
Income from continuing operations
-2,778
-3,102
-3,555
-5,540
-6,678
-
Net income
-2,778
-3,102
-3,555
-5,540
-6,678
-
Net income available to common shareholders
-2,778
-3,102
-3,555
-5,540
-6,678
-
Basic EPS
-0.01
-
-0.01
-0.01
-0.02
-0.02
Diluted EPS
-0.01
-
-0.01
-0.01
-0.02
-0.02
Basic average shares
419,502
-
419,470
408,223
393,252
386,594
Diluted average shares
419,502
-
419,470
408,223
393,252
386,594